542 related articles for article (PubMed ID: 17493468)
1. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
[TBL] [Abstract][Full Text] [Related]
2. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Patti G; Nusca A; Di Sciascio G
Am J Cardiol; 2008 Nov; 102(10):1328-34. PubMed ID: 18993150
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
5. The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.
Kumbhani DJ; Bavry AA; Kamdar AR; Helton TJ; Bhatt DL
Am Heart J; 2008 Apr; 155(4):640-7. PubMed ID: 18371470
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.
Mahmud E; Bromberg-Marin G; Palakodeti V; Ang L; Creanga D; Demaria AN
J Am Coll Cardiol; 2008 Jun; 51(25):2385-95. PubMed ID: 18565394
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
Maresta A; Varani E; Balducelli M; Varbella F; Lettieri C; Uguccioni L; Sangiorgio P; Zoccai GB;
Am J Cardiol; 2008 Jun; 101(11):1560-6. PubMed ID: 18489933
[TBL] [Abstract][Full Text] [Related]
11. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
Qasim A; Cosgrave J; Latib A; Colombo A
Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis.
Gurm HS; Boyden T; Welch KB
Am Heart J; 2008 Apr; 155(4):630-9. PubMed ID: 18371469
[TBL] [Abstract][Full Text] [Related]
15. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries.
Steinberg DH; Mishra S; Javaid A; Slottow TL; Buch AN; Roy P; Okabe T; Smith KA; Torguson R; Xue Z; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Mar; 99(5):599-602. PubMed ID: 17317356
[TBL] [Abstract][Full Text] [Related]
18. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
[TBL] [Abstract][Full Text] [Related]
19. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.
Hermiller JB; Raizner A; Cannon L; Gurbel PA; Kutcher MA; Wong SC; Russell ME; Ellis SG; Mehran R; Stone GW;
J Am Coll Cardiol; 2005 Apr; 45(8):1172-9. PubMed ID: 15837245
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]